MetabolicVery common; estimated to affect a large share of adults in Western countries, often without diagnosis

Insulin Resistance

Also known as: Impaired insulin sensitivity

Insulin resistance is a condition in which the body's cells, particularly in muscle, fat and the liver, stop responding properly to insulin, the hormone that moves glucose from the blood into cells for energy. To compensate, the pancreas produces more and more insulin, which can keep blood sugar normal for years. Over time the pancreas may not keep up, blood sugar rises, and prediabetes or type 2 diabetes develops. Insulin resistance is also at the root of metabolic syndrome and is linked to fatty liver disease, polycystic ovary syndrome, high blood pressure and heart disease. It is driven mainly by excess abdominal fat, inactivity and genetics, and it responds very well to weight loss, exercise and dietary change.

Last updated November 10, 2026

Understanding Insulin Resistance

Insulin resistance is a state in which muscle, liver and fat cells need more insulin than normal to do the same job of moving glucose out of the blood and switching off glucose production in the liver. The pancreas compensates by making more, so for years blood sugar looks fine while insulin runs high, which is why it is usually invisible on a standard panel. It is very common: an analysis of US national survey data found that about 40 percent of adults aged 18 to 44 without diabetes already met criteria for insulin resistance, and the CDC estimates that 98 million American adults, 38 percent, have prediabetes, the stage at which glucose begins to rise. Risk tracks waist size, inactivity, family history, ancestry (South Asian, Hispanic, Black and Native American adults develop it at lower body weights), sleep debt, and some drugs, including corticosteroids, several antipsychotics and certain HIV medications. Polycystic ovary syndrome, gestational diabetes and fatty liver disease are often its first visible expressions.

The mechanism is largely about fat in the wrong places. When fat tissue is full or inflamed, fatty acids spill into muscle and liver, where lipid intermediates (diacylglycerols and ceramides) interfere with the insulin receptor's signaling chain; the muscle takes up less glucose and the liver keeps making it after meals. Visceral fat adds inflammatory signals, and high insulin itself promotes further fat storage, which is the self-reinforcing loop behind 'I cannot lose weight'. The beta cells of the pancreas can run at high output for a decade or more, but in people with a genetic susceptibility they eventually tire, fasting glucose creeps above 100 mg/dL, and prediabetes progresses to type 2 diabetes at roughly 5 to 10 percent per year if nothing changes. The mechanism is reversible early: muscle glucose uptake rises within hours of exercise and liver fat falls within days of a calorie deficit.

There is no drug approved for insulin resistance as such; the goal of care is to stop progression. The Diabetes Prevention Program randomized 3,234 adults with prediabetes to intensive lifestyle coaching (a 7 percent weight-loss goal and 150 minutes of weekly activity), metformin or placebo; over 2.8 years lifestyle cut new diabetes by 58 percent and metformin by 31 percent, and at 15-year follow-up the lifestyle group still had 27 percent fewer cases. The American Diabetes Association Standards of Care recommend referral to a structured prevention program for everyone with prediabetes and say metformin may be considered, particularly under age 60, with a BMI of 35 or more, or after gestational diabetes. Insulin resistance is measured indirectly with fasting glucose and A1c, and more directly with a fasting insulin to calculate HOMA-IR (glucose in mg/dL times insulin in microunits per mL, divided by 405); values above about 2.5 to 3 suggest resistance, though there is no agreed cutoff and laboratories differ. A triglyceride-to-HDL ratio above 3 is a useful proxy on a standard lipid panel.

Supplements sit well below diet, exercise and sleep, but a few have respectable trials. Berberine has the strongest: a 2008 head-to-head found 500 mg three times daily lowered A1c about as much as metformin over 3 months, and pooled analyses confirm fasting glucose and insulin fall. Magnesium improves HOMA-IR in people who start low in it, which is common. Myo-inositol has good evidence in PCOS and for preventing gestational diabetes, and weaker evidence elsewhere. Cinnamon lowers fasting glucose modestly in meta-analyses without moving A1c; chromium helps only people with diabetes, and only a little; alpha-lipoic acid has mostly intravenous or short oral trials. Vitamin D in the 2,423-person D2d trial did not significantly prevent diabetes, although people who were deficient at the start did better. Apple cider vinegar, bitter melon, gymnema and 'blood sugar support' blends have single small or inconsistent trials and are not worth the money. Nothing in a capsule substitutes for muscle you build or weight you lose.

The most common mistake is to fixate on carbohydrates and ignore muscle and sleep. Cutting refined carbohydrate helps, but a diet-only approach loses lean mass along with fat, and muscle is where 70 to 80 percent of insulin-stimulated glucose goes. Two or three resistance sessions a week raise insulin sensitivity independent of weight loss; in the HART-D trial of 262 adults, combining aerobic and resistance training lowered A1c more than either alone. Sleep is the other missed lever: restricting 11 healthy men to 4 hours a night for 6 nights cut their glucose tolerance by 40 percent, and habitual sleep under 6 hours roughly doubles the risk of developing diabetes, so a fasting glucose that drifts up after a bad month of sleep is not a diet failure. The second mistake is testing only fasting glucose: it is the last number to move. Ask for a fasting insulin alongside glucose and A1c, and watch triglycerides and HDL cholesterol, which respond within weeks and tell you whether what you are doing is working.

At a Glance

Common symptoms
Often no symptoms in the early stages, Increased hunger, cravings for sweets and weight gain, especially around the waist, Fatigue, particularly after meals
Main treatments
Weight loss, even 5 to 10 percent of body weight, which substantially improves insulin sensitivity, Regular aerobic exercise plus resistance training, which increases muscle glucose uptake for hours after each session, A diet based on vegetables, whole grains, legumes, lean protein and healthy fats while cutting sugary drinks, refined carbohydrates and processed foods
Category
Metabolic · Very common; estimated to affect a large share of adults in Western countries, often without diagnosis
See a doctor if
You are overweight with a large waist, a family history of diabetes, or other risk factors and have not had your blood sugar checked

Symptoms

Often no symptoms in the early stages
Increased hunger, cravings for sweets and weight gain, especially around the waist
Fatigue, particularly after meals
Difficulty losing weight despite effort
Dark, velvety skin patches on the neck, armpits or groin (acanthosis nigricans)
Skin tags
In women, irregular periods or features of polycystic ovary syndrome

Causes

  • Excess body fat, particularly visceral fat around the abdominal organs, which releases substances that interfere with insulin signalling
  • Physical inactivity, since muscle contraction is a major driver of glucose uptake
  • A diet high in refined carbohydrates, added sugars and ultra-processed foods
  • Genetic factors affecting insulin signalling and fat storage
  • Chronic inflammation and elevated stress hormones such as cortisol
  • Sleep deprivation and sleep apnea

Risk Factors

  • Being overweight, with a waist circumference above 40 inches (102 cm) in men or 35 inches (88 cm) in women
  • A family history of type 2 diabetes
  • A sedentary lifestyle
  • Polycystic ovary syndrome or a history of gestational diabetes
  • Certain medications, including corticosteroids and some antipsychotics
  • Smoking and poor sleep

Diagnosis

  • There is no single routine test; diagnosis is based on risk factors, examination and blood results
  • Fasting glucose and HbA1c to detect prediabetes or diabetes
  • Fasting insulin or the HOMA-IR calculation in some settings, though these are not standardized for routine use
  • Lipid profile, often showing high triglycerides and low HDL cholesterol
  • Blood pressure, waist measurement and liver tests, which help identify associated metabolic syndrome or fatty liver

Treatment

  • Weight loss, even 5 to 10 percent of body weight, which substantially improves insulin sensitivity
  • Regular aerobic exercise plus resistance training, which increases muscle glucose uptake for hours after each session
  • A diet based on vegetables, whole grains, legumes, lean protein and healthy fats while cutting sugary drinks, refined carbohydrates and processed foods
  • Medications such as metformin when blood sugar is already raised or risk is high, prescribed by your doctor
  • Treating associated conditions such as high blood pressure, high cholesterol, sleep apnea or PCOS
  • Supportive: improving sleep duration and quality and managing stress
  • Supportive: stopping smoking and limiting alcohol

Natural remedies for insulin resistance: what the evidence says

Ranked by the strength of human evidence for insulin resistance specifically. These sit alongside medical care, not in place of it.

  1. Berberine

    Moderate evidence

    In a 2008 pilot, 36 adults with newly diagnosed type 2 diabetes took berberine 500 mg three times daily or metformin for 3 months and A1c fell by about 2 percentage points in both groups; in a second study of 48 people, adding berberine lowered fasting insulin by 28 percent and HOMA-IR by 45 percent. A 2015 meta-analysis of 27 trials (2,569 people) found reductions in fasting glucose, A1c and triglycerides comparable to oral diabetes drugs, though the trials were short and mostly from China.

    Studied dose
    500 mg berberine HCl two to three times daily with meals for 8 to 12 weeks.
    Cautions
    Constipation and diarrhea are common; it inhibits CYP3A4 and CYP2D6 and raises levels of cyclosporine, some statins and metformin. Avoid in pregnancy and breastfeeding (risk of newborn jaundice) and with glucose-lowering drugs unless monitored.
  2. Magnesium Glycinate

    Moderate evidence

    A 2016 meta-analysis of 18 randomized trials (670 people) found magnesium supplements improved HOMA-IR and fasting glucose, with the benefit concentrated in people who were magnesium-deficient at the start or who supplemented for more than 4 months. In a 6-month placebo-controlled trial of 52 overweight, insulin-resistant but non-diabetic adults, 365 mg magnesium daily reduced fasting glucose and HOMA-IR.

    Studied dose
    300 to 400 mg elemental magnesium daily as glycinate for at least 4 months; ask for a serum magnesium first, remembering it misses mild deficiency.
    Cautions
    Loose stools; split the dose or reduce it. Avoid supplementing in kidney disease without advice, and separate from quinolone and tetracycline antibiotics and bisphosphonates by 2 hours.
  3. Myo-Inositol

    Moderate evidence

    Myo-inositol works as a second messenger in insulin signaling. In PCOS, a 2017 meta-analysis of randomized trials found 2 to 4 g daily reduced fasting insulin and HOMA-IR and improved ovulation; in 220 women at risk, 4 g daily from the first trimester cut gestational diabetes from 15 to 6 percent. Evidence in men and in women without PCOS is limited to small trials.

    Studied dose
    2 g myo-inositol twice daily, often combined with D-chiro-inositol in a 40:1 ratio, for at least 3 months.
    Cautions
    Mild nausea and gas at doses above 12 g daily. Additive glucose lowering with metformin; may affect mood in bipolar disorder.
  4. Cinnamon

    Preliminary evidence

    A 2013 meta-analysis of 10 trials (543 people with type 2 diabetes) found cinnamon lowered fasting glucose by about 25 mg/dL and improved lipids but did not change A1c, and the trials were short and inconsistent. Most products are cassia cinnamon, which contains coumarin, a liver toxin at high daily doses.

    Studied dose
    1 to 3 g cassia cinnamon powder daily, or a Ceylon cinnamon or water-extract product, which contain little coumarin, for 6 to 12 weeks.
    Cautions
    Cassia above about 1 teaspoon (2.5 g) daily can exceed the tolerable coumarin limit; choose Ceylon for daily use. Additive with glucose-lowering drugs; may interact with liver-metabolized medicines.
  5. Chromium

    Preliminary evidence

    A 2014 meta-analysis of 25 randomized trials found chromium picolinate modestly lowered fasting glucose and A1c in people with type 2 diabetes (A1c by about 0.6 points at 200 to 1,000 micrograms daily) but had no effect in people without diabetes, and trials in prediabetes and insulin resistance have been negative or tiny.

    Studied dose
    200 to 400 micrograms chromium picolinate daily; not worth continuing beyond 3 months if blood tests do not move.
    Cautions
    Rare reports of kidney and liver injury at high doses; it may increase the effect of insulin and diabetes drugs, and it reduces levothyroxine absorption, so separate the two by 3 to 4 hours.
  6. Alpha-Lipoic Acid (ALA)

    Preliminary evidence

    Intravenous alpha-lipoic acid raised insulin-stimulated glucose disposal by about 30 percent in small studies of people with type 2 diabetes, and oral doses of 600 to 1,800 mg daily for 4 weeks produced smaller improvements in insulin sensitivity in a 74-person trial. Longer oral trials in insulin resistance are lacking; its better evidence is for diabetic nerve pain.

    Studied dose
    600 mg once or twice daily on an empty stomach.
    Cautions
    Nausea and skin rash; lowers blood glucose further with diabetes drugs; rare insulin autoimmune syndrome in people carrying HLA-DR4; can slightly lower thyroid hormone levels.
  7. Vitamin D

    Preliminary evidence

    Low vitamin D is associated with insulin resistance, but trials correcting it have been disappointing: the D2d trial gave 2,423 adults with prediabetes 4,000 IU daily for a median 2.5 years and diabetes developed in 9.4 versus 10.7 percent per year, a non-significant 12 percent reduction, with a larger effect in those starting below 12 ng/mL. Worth correcting a deficiency; not a treatment for insulin resistance.

    Studied dose
    1,000 to 2,000 IU vitamin D3 daily if your level is below 20 ng/mL; 4,000 IU was used in the trials.
    Cautions
    Doses above 4,000 IU daily need calcium monitoring; use care with thiazides, digoxin and granulomatous disease such as sarcoidosis.

What matters day to day

  • Lift weights 2 to 3 times a week: resistance training raises insulin sensitivity for up to 48 hours after each session independent of weight loss, and in HART-D the combined aerobic-plus-resistance group lowered A1c the most.
  • Walk for 10 to 15 minutes after each meal: three short post-meal walks lowered 24-hour glucose more than a single 45-minute walk in a crossover study of older adults at risk of diabetes.
  • Target a 7 percent weight loss and 150 minutes of brisk activity a week: this exact prescription cut new diabetes by 58 percent in the Diabetes Prevention Program.
  • Sleep 7 to 9 hours on a consistent schedule: six nights of 4-hour sleep cut glucose tolerance by 40 percent in healthy men, and habitual sleep under 6 hours roughly doubles diabetes risk.
  • Swap sugar-sweetened drinks and refined grains for fiber, legumes and protein: each daily sugary drink is linked to about 25 percent higher diabetes risk, and 25 to 30 g of fiber a day improves insulin sensitivity in trials.
  • Get measured properly and then re-measured: ask for fasting glucose, A1c, fasting insulin, triglycerides and HDL cholesterol, and repeat in 3 to 6 months to see whether the plan is working.

Prevention

  • Keep your waist size and body weight within a healthy range
  • Be active every day and sit less; even short walks after meals help
  • Build and maintain muscle with strength training
  • Limit sugary drinks, sweets and refined grains, and eat plenty of fibre
  • Prioritize 7 to 9 hours of sleep
  • Have regular checks of blood sugar, blood pressure and cholesterol if you have risk factors

When to See a Doctor

  • You are overweight with a large waist, a family history of diabetes, or other risk factors and have not had your blood sugar checked
  • Dark, velvety patches of skin or multiple skin tags appear
  • Increased thirst, frequent urination or unexplained fatigue
  • Irregular periods, excess facial hair or difficulty conceiving, which may indicate PCOS
  • You want support with a structured weight loss or exercise plan

Frequently Asked Questions

References

  1. Knowler WC, Barrett-Connor E, Fowler SE, et al. (Diabetes Prevention Program Research Group). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine (2002)
  2. Diabetes Prevention Program Research Group. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes and Endocrinology (2015)
  3. American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes: Prevention or Delay of Diabetes and Associated Comorbidities. Diabetes Care (2025)
  4. Parcha V, Heindl B, Kalra R, et al.. Insulin resistance and cardiometabolic risk profile among nondiabetic American young adults: insights from NHANES. Journal of Clinical Endocrinology and Metabolism (2022)
  5. Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism (2008)
  6. Simental-Mendia LE, Sahebkar A, Rodriguez-Moran M, Guerrero-Romero F. A systematic review and meta-analysis of randomized controlled trials on the effects of magnesium supplementation on insulin sensitivity and glucose control. Pharmacological Research (2016)
  7. Allen RW, Schwartzman E, Baker WL, Coleman CI, Phung OJ. Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis. Annals of Family Medicine (2013)
  8. Pittas AG, Dawson-Hughes B, Sheehan P, et al.. Vitamin D supplementation and prevention of type 2 diabetes (D2d). New England Journal of Medicine (2019)
  9. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet (1999)
  10. Church TS, Blair SN, Cocreham S, et al.. Effects of aerobic and resistance training on hemoglobin A1c levels in patients with type 2 diabetes: a randomized controlled trial (HART-D). JAMA (2010)

Related Conditions

Related Reading

Have questions about Insulin Resistance?

Ask Mother Nature AI for personalized, evidence-based guidance.

Medical Disclaimer: This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.

Content reviewed against peer-reviewed medical literature and clinical guidelines. Read our editorial standards.